AltrixBio

Cambridge, United States

AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric surgery.

$1.2M raised

May 2025

Venture - Series Unknown

Top Investors

FlybridgeTaihill VentureXFactor VenturesWalnut Venture AssociatesArizona Tech Investors

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AltrixBio raised?

AltrixBio has raised $1.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.

Who are AltrixBio's investors?

AltrixBio's investors include Flybridge, Taihill Venture, XFactor Ventures, Walnut Venture Associates, Arizona Tech Investors.

Where is AltrixBio headquartered?

AltrixBio is headquartered in Cambridge, United States.

What does AltrixBio do?

AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric surgery.

What stage is AltrixBio at?

AltrixBio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 5, 2025.

MLA

"AltrixBio — Funding & Investors." VCBacked, May 5, 2025, https://www.vcbacked.co/company/altrixbio. Accessed June 4, 2026.

APA

VCBacked. (2025). AltrixBio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/altrixbio

Wikipedia (cite web)

{{cite web |title=AltrixBio — Funding & Investors |url=https://www.vcbacked.co/company/altrixbio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 5, 2025.